Edwards Lifesciences Fundamental Relationships

EW -- USA Stock  

USD 153.90  0.30  0.20%

The Drivers Module shows relationships between Edwards Lifesciences's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of Edwards Lifesciences Corporation over time as well as its relative position and ranking within its peers. Additionally see Investing Opportunities

Edwards Lifesciences Total Asset vs. Price to Book Fundamental Analysis

Edwards Lifesciences Corporation is rated # 2 in price to book category among related companies. It is rated below average in total asset category among related companies fabricating about  408,380,282  of Total Asset per Price to Book.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is accounting value of assets minus liabilities.
Edwards Lifesciences 
P/B 
 = 
MV Per Share 
BV Per Share 
=
9.94 times
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Edwards Lifesciences 
Total Asset 
 = 
Tangible Assets 
Intangible Assets 
=
4.06 B
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of a company property, and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.

Edwards Lifesciences Total Asset Comparison

  Total Asset 
      Edwards Lifesciences Comparables 
Edwards Lifesciences is rated below average in total asset category among related companies.

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Revenue

Edwards Lifesciences Revenue Analysis
Edwards Lifesciences Corporation is rated below average in revenue category among related companies. Market size based on revenue of Healthcare Products industry is currently estimated at about 711.64 Billion. Edwards Lifesciences adds roughly 3.45 Billion in revenue claiming only tiny portion of equities under Healthcare Products industry.